1. The activities of enzymes of the urea cycle [carbamoyl phosphate synthetase, ornithine transcarbamoylase, argininosuccinate synthetase, argininosuccinase (these last two comprising the arginine-synthetase system) and arginase] have been measured in control, alloxan-diabetic and glucagon-treated rats. In addition, measurements were made on alloxan-diabetic rats treated with protamine-zincinsulin. 2. Treatment of rats with glucagon for 3 days results in a marked increase in the activities ofthree enzymes ofthe urea cycle (carbamoyl phosphate synthetase, argininosuccinate synthetase and argininosuccinase). The pattern of change in the alloxan-diabetic group is very similar to that of the glucagon-treated group, although the magnitude of the change was much greater. 3. Comparison was made of the actual and potential rate of urea synthesis in normal and diabetic rats. In both groups the potential rate of urea production, as measured by the activity of the rate-limiting enzyme, argininosuccinate synthetase, slightly exceeds the actual rate of synthesis by liver slices in the presence of substrates. The relative activities of the actual and potential rates were similar in the two groups of animals, this ratio being 1: 0-70. 4. In the alloxan-diabetic rats treated with protamine-zinc-insulin for 2-5 or 4 days there was a marked increase in liver weight. This was associated with a rise in the total hepatic activity of the urea-cycle enzymes located in the soluble fraction of the cell (the arginine-synthetase system and arginase) after 2-5 days of treatment. After 4 days of treatment the concentration of these enzymes/g. of liver decreased, and the total hepatic content then reverted to the untreated alloxan-diabetic value. 5. No effects of glucagon or of insulin in vitro could be found on the rate of urea production by liver slices. 6. The present results are discussed in relation to how far this pattern of change is typical of conditions resulting in a high urea output, and comparison has been made with other values in the literature.
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It has been known for many years that the diabetic state is associated with a greatly increased nitrogen excretion, and this and the effect of insulin in causing nitrogen retention have been widely studied (Minkowski, 1893; Atchley, Loeb, Richards, Benedict & Driscoll, 1933; Soskin & Levine, 1946; Chaikoff & Forker, 1950) . More recently glucagon has been shown to be a hormone closely associated with protein catabolism, increased amino acid breakdown and increased urea synthesis (Tyberghein, 1953; Salter, Davidson & Best, 1957; Best, 1959; Miller, 1960) . Thus these two hormones, secreted by the pancreas, have powerful and antagonistic effects on both carbohydrate and nitrogen metabolism (see de Duve, 1953; Lukens, 1959; Randle, 1963 Though certain of the urea-cycle enzymes have been studied in alloxan-diabetic-rat liver, namely arginase (Folley & Greenbaum, 1949 ) and the overall arginine-synthetase system (Freedland & Sodikoff, 1962) , there has as yet been no systematic study of the overall pattern of change of all five enzymes of this cycle. Glucagon also presents an interesting problem, particularly since the studies of Miller (1960) , who showed an in vitro effect of this hormone in promoting urea synthesis by isolated perfused liver.
The systematic nomenclature and number adopted by the International Union of Biochemistry Commission on Enzymes for the five urea-cycle enzymes are as follows: carbamoyl phosphate synthetase (adenosine triphosphate-carbamate phosphotransferase, EC 2.7.2.2), ornithine transcarbamoylase (carbamoyl phosphate-L-ornithine carbamoyltransferase, EC 2.1.3.3), argininosuccinate synthetase [L-citrulline-L-aspartate ligase (adenosine 5'-phosphate), EC 6.3.4.5], argininosuccinase (L-argininosuccinate arginine-lyase, EC 4.3.2.1) and arginase (L-arginine ureohydrolase, EC 3.5.3.1). The influence of pancreatic hormones on the activities of these enzymes has been investigated, since the overall effect of increased urea output could be induced by an alteration in either the rate-limiting enzyme, argininosuccinate synthetase, alone, or by more widespread changes in this enzyme system. In the results described below on the effects of diabetes and glucagon treatment on the pattern of change of the activities of the urea-cycle enzymes, the most striking result that has emerged is the close parallelism of the modification produced by these two treatments. In each case the total hepatic activities of the same three enzymes, carbamoyl phosphate synthetase, argininosuccinate synthetase and argininosuccinase, were increased, whereas those of ornithine transcarbamoylase and arginase were relatively unchanged. METHODS Materials. Commericalreagents were used with the exception of a-isonitrosopropiophenone, which was synthesized by the method of , and carbamoyl phosphate, which was synthesized by the method of Spector, Jones & Lipmann (1957) . These two compounds were prepared by Miss M. W. Gurney. Argininosuccinic acid was a product of California Corp. for Biochemical Research, Los Angeles, Calif., U.S.A. Glucagon preparations were kindly given by Novo Terapeutisk Laboratorium, Copenhagen, Denmark, and by Eli Lilly Co., Indianapolis, Ind., U.S.A.
alucagon treatment of rats. Young male rats (initial body wt. 150-160 g.) were used. Three doses of glucagon, each of 100 ,tg., were administered daily by subcutaneous injection for 2 days and the rats were killed on the third day, 1 hr. after the administration of the last 100 ,ug. dose of glucagon. Control animals received injections of0.9% NaCl. Rats were pair-fed during the period of treatment. In most cases rats were kept in individual metabolism cages and the daily urea excretion was measured.
Diabetic rats. Adult male rats (initial body wt. approx. 250 g.) were starved for 48 hr. and then ailoxan monohydrate was injected subcutaneously, the dose being 19 mg./100 g. body wt. (Kass & Waisbren, 1945) . The alloxan was dissolved in 0-1 M-acetate buffer, pH 4.5, before injection, to minimize inactivation of alloxan, according to the method of Klebanoff& Greenbaum (1954) . The alloxandiabetic rats were given 1 unit of protamine-zinc-insulin daily for the first week after administration of alloxan; this greatly increased the overall survival rate. Thereafter insulin was withdrawn and the rats were maintained on the stock diet ad lib. for 2 weeks. At this stage the diabetic rats were transferred to individual cages and were pair-fed with control rats of the same age and body weight. The period of paired feeding lasted for a further 2 weeks, and the rats were killed 5 weeks after the administration ofalloxan and 4 weeks after the cessation of insulin treatment. In most cases the diabetic and control rats were kept in metabolism cages for the final 3 days of the experimental period, and the daily urea and glucose outputs were measured. The urea excreted was measured by the colorimetric method of Archibald (1945) and the glucose by the method of Nelson (1944) . Diabetic rats treated with protamine-zinc-insulin were pair-fed with diabetic rats.
Urea-cycle enzymes. The activities of the urea-cycle enzymes were measured essentially according to the method of Brown & Cohen (1959) as modified by McLean & Gurney (1963) . Liver was homogenized in 0-1% cetyltrimethylammonium bromide solution, in the ratio 1 g. of liver to 9-0 ml. of solution. The supernatant fraction after centrifugation at 4000 g for 15 min. at 50 was used for the assay of all enzymes except arginase. This latter enzyme was estimated by diluting one part of the whole homogenate prepared in 0.1% cetyltrimethylammonium bromide with 9 parts of 'manganese saline' (8 g. of MnSO4,4H20 and 9 g. of NaCl/l.) and incubating for 30 min. at 370 to activate the enzyme in accordance with the method of Folley & Greenbaum (1948) . The enzyme activities were measured as described by McLean & Gurney (1963) with one exception, that of carbamoyl phosphate synthetase.
Carbamoyl phosphate syntheta8e. It was observed that liver homogenates prepared from alloxan-diabetic rats gave very high enzymic blank values for urea content in the absence of added substrate. Thus 0-1 ml. of supernatant fraction, prepared as described above, sometimes contained up to 15 ,ug. of urea as estimated by the sensitive colorimetric method with a-isonitrosopropiophenone described by Archibald (1945) . This high value could be allowed for in the assay of all the enzymes involving the final determination of the urea content of the incubation mixture by setting up suitable blank values. When citrulline was the end product measured the problem presented greater difficulties, owing to the interaction of urea and citrulline in the diacetylmonoxime reaction of Archibald (1944) . The correction for this interference, which is of considerable importance in the assay of carbamoyl phosphate-synthetase activity, is fully discussed in the Addendum (McLean, Novello & Gurney, 1965) . In essence, this correction is necessary because it was found that when urea and citrulline were present together Table 1 . Interaction of citrulline and urea in the diacetylmonoxime colour reaction
The difference in E490., due to citrulline is that obtained in the presence of urea minus the colour due to urea alone. This was expressed as a percentage of the colour with citrulline alone and this is shown in the last column as percentage potentiation of colour. The colour reaction of Archibald (1944) Table 1 ). The greatest effect is at the lowest concentration of citrulline, and these percentage changes illustrate the importance of this correction factor. Ornithine transcarbamoylase. The activity of this enzyme in liver is normally so great that only 0-01 ml. ofsupernatant fraction, prepared as described above, is added to 2-0 ml. ofreaction mixture. Krebs & Henseleit (1932) , Krebs (1952) and Dickens & Weil-Malherbe (1943) . The final assay medium adopted included: 100 ,umoles ofNH4Cl; 10 ,umoles of ornithine; 5 0 ml. of Krebs-Ringer bicarbonate medium (Umbreit, Burris & Stauffer, 1949) ; 200 mg. of rat-liver slices. The gas phase was 02+CO2 (95:5) , and the total volume of the reaction mixture was 5-5 ml. The tissue slices were incubated at 370 for 1 hr. at the end of which period the flasks were removed from the bath and the reaction was stopped by the addition of 0 5 ml. of 10 N-perchloric acid. The urea content was determined, with 1.0 ml. samples of the supernatant fraction after removal of the precipitated proteins by centrifugation, by means of the colorimetric method with x-isonitrosopropiophenone described by Archibald (1945 The effect of variations in each substrate in turn, the remaining components being kept at the concentration described in the basic assay mixture, is shown in Fig. 4 . The substitution of alanine for NH4C1 as a source of amino groups for urea formation led to a very low rate of urea formation (Fig. 4) .
The addition of aspartic acid had little effect on urea synthesis by slices, and no eonsistent difference could be found when N-acetylglutamic acid, the cofactor required for carbamoyl phosphate synthetase, was added to the medium. The lack of effect in these cases could be due to their rate of penetration into the liver slices (see Ratner, 1954) . The addition of glucose to the medium in which liver slices were incubated did not increase urea formation. This was tested since the amount of endogenous glucose and glycogen in the liver could be very different in control, diabetic and glucagon-treated rats, and the negative results are in keeping with the work of Krebs & Henseleit (1932) , who found that glucose caused no stimulation in urea production whereas pyruvate, lactate or fructose all caused a marked increase in the rate of urea synthesis by liver slices.
Dickens & Weil-Malherbe (1943) in their studies on urea synthesis by primary hepatomas and liver also fortified the medium with added lactate. In the present experiment no such additional compound was used since such profound changes occur in carbohydrate metabolism of diabetic rats that it seemed possible that the presence of fructose, pyruvate or lactate would add further difficulty to the interpretation of the results on urea production by liver slices. Moreover, preliminary experiments with liver slices from control rats indicated that fructose, glucose, lactate or pyruvate did not cause any marked stimulation of urea synthesis. Unwashed liver slices were used in the present experiments, in contrast with the work of Krebs & Henseleit (1932) experimenits with the addition of NH4Cl and ornithine corresponds well with the values quoted by Krebs & Henseleit (1932) and is only a little lower than those of Dickens & Weil-Malherbe (1943) , who also added lactate to the medium.
Determination of nucleic acids. The extraction procedure adopted was that of Schneider (1946) . DNA was estimated by a modification of the diphenylamine method of Dische (1930) described by Burton (1956) . RNA was determined by the orcinol method of Mejbaum (1939) , the time of heating being increased to 45 min.
Determination of protein. The protein content of whole homogenates was estimated by the colorimetric method of Lowry, Rosebrough, Farr & Randall (1951) .
Statistical treatment of result8. Fisher's t test was used, a difference between two mean values beinig regarded as significant ifP was no greater than 0-05. Values ofP greater than 0-1 are quoted in the Tables as N.S. (not significant).
RESULTS
Treatment ofrats with glucagon for 3 days results in a marked increase in the activity of three of the enzymes of the urea cycle, carbamoyl phosphate synthetase, argininosuccinate synthetase and argininosuccinase, the last two comprising the argininesynthetase system (see Table 2 and Fig. 5 ). The pattern of change in the alloxan-diabetic group of rats is very similar to that of the glucagon-treated Table 2 . Effect of glucagon treatment on the activities of the urea-cycle enzymes in rat liver
Results are expressed as means+ s.E.M. A unit of enzyme activity is defined as the amount catalysing the formation of 1 pemole of urea or citrulline/hr. under the conditions of assay. Fisher's P values are given and are regarded as significant if P is less than 0 05; values of P greater than 0-1 are quoted as not significant (N.S.). The rats treated with glucagon for 3 days received three daily doses of Novo Terapeutisk glucagon (100 ,ug./dose) subcutaneously for 3 days. The protein contents, in mg./10 ml. of cetyltrimethylammonium bromide extract (equivalent to 1 g. of liver), were 109 + 7 and 96 + 9 for control and glucagon-treated rats respectively. The group treated for 2 hr. received a single injection of glucagon (200 ,ug.) and the controls were injected with 0.9% NaCl.
In this group urea synthesis by 200 mg. of liver slices, incubated with 10 Iemoles of ornithine and 100 ,umoles of NH4Cl with 5 ml. of Krebs-Ringer bicarbonate medium, gas phase 02+ C02 (95: 5), was determined as described in the Methods section. group: although the magnitude of the change is 160C much greater (see Table 3 and Fig. 6 (Miller, 1960) , attempts were resent twice the S.E.M. The horizontal broken line made to show short-term effects of this hormone rbitarily fixed control value of 100%, the shaded in vivo or in vitro on urea-cycle enzymes and on either side of this broken line representing twice the urea synthesis by liver slices. Certain of these r the control group. The rats were treated with a for 3 days, receiving each day three doses of Novo restre shown inzTbe 2.cParil interest 'tisk glucagon (100 pg./dose) subcutaneously. Each tredtonthe three enzymes increased in the 3-day ontains seven or more animals. A, Carbamoyl treatmentperod, andthese were measuredinthese Lte synthetase; B, ornithine transcarbamoylase; short-term experiments in an attempt to show Line-synthetase system; D, argininosuccinase; E, which enzyme responded most rapidly to the hormonal treatment. Rats were killed 2 hr. after 416P.
the intraperitoneal administration of a 200 ,ig. also failed to increase ulrea production during a 2 hr. dose of glucagon: neither the activities of the incubation period: average values from five sepaenzymes nor the synthesis of urea by liver slices rate experiments are 52-4 + 2 6 and 51*3 + 1*6 ,umoles was altered. for the control group. Each group contains 11 rats. succmase. The activity of this last-named enzyme A, Carbamoyl phosphate synthetase; B, ornithine trans-was still significantly higher in the diabetic group in carbamoylase; C, arginine-synthetase system; D, arginino. coma than in the control group and was not signisuccinase; E, arginase.
ficantly different from that of the main diabetic Table 6 . Activities of the urea-cycle enzymes in liver from alloxan-diabetic rats and alloxan-diabetic rats treated with insulin
Results are expressed as means+s.E.M. A unit of enzyme activity is defined as the amount catalysing the formation of 1 umole of urea or citrulline/hr. under the conditions of the assay. Fisher's P values are given for the comparison of the diabetic rats treated with insulin with the diabetic group, and are regarded as significant if P is less than 0-05; values of P greater than 0-1 are quoted as not significant (N.S.). The insulin-treated rats received daily subcutaneous injections, each of2 units ofprotamine-zinc-insulin, and a final injection ofcrystalline insulin (2 units) 1 hr. before being killed for estimation of the enzyme activities. Comparison has been made of the actual and potential rates of urea synthesis in normal and diabetic rats (Table 4 ). In both groups of rats the potential rate of urea production, as measured by the activity of the rate-limiting arginine-synthetase system, exceeds the actual rate of synthesis by the tissue slices in the presence of substrate; their relative activities were closely similar in the two groups of rats, the ratios being 1: 0-71 in the control group and 1: 0-70 in the diabetic group.
The effects of insulin treatment on the activities of the urea-cycle enzymes in normal and diabetic rats are given in Tables 5 and 6 . Treatment with insulin has little or no effect on the activities of the urea-cycle enzymes in normal rats, although here again the fall in blood sugar concentration and the secondary consequences of this must be borne in mind. There was a tendency for the activity of liver arginase to be increased, a change significant only when expressed as total activity/100 g. body wt. This effect should be re-examined with experiments in which the blood sugar is kept high during the treatment with insulin, since this can cause considerable modification in the response to insulin in vivo; Chaikoff & Larson (1935) have an example of this in relation to changes in uric acid concentrations.
In the group of diabetic rats treated with insulin for 2 5 days an unexpected and marked rise occurred in the activities of the enzymes of the urea cycle located in the soluble fraction ofthe cell, the enzymes of the arginine-synthetase system and arginase, when expressed either as total units (Fig. 7 ) or as total units/100 g. body wt. (Table 6 ). The units of enzyme activity/g. of liver remained unchanged in these insulin-treated diabetic animals compared with those of the diabetic group, with the exception of argininosuccinase (Table 6) , and the increase was almost entirely due to the striking increase in liver weight, which almost doubled as a result of this treatment. Since, in general, insulin treatment tends to reverse the changes occurring in the diabetic animal, this experiment was repeated with longer periods (4 days) of insulin treatment (Table 6) , and here the concentrations ofall the urea-cycle enzymes (units/g. of liver) fell in relation to the values for diabetic rats with the exception of arginase; these changes were highly significant statistically. However, since the liver was still markedly increased in size the total hepatic contents of all the urea-cycle enzymes were close to the values for diabetic rats (Table 6 and Fig. 7 ). Clearly this period of treatment shows a turning point and the beginning of the return of the activities of the urea-cycle enzymes towards control normal values, but longer periods of treatment or higher doses of protamine-zinc-insulin would be needed to show this effect.
The composition of the livers in these groups of animals showed that the amount of RNA P and protein/g. of tissue did not alter significantly as a result of insulin treatment, although there was a slight fall in the DNA P/g. of liver. It is therefore apparent that there is a considerable increase in the total liver protein and RNA P as a result of insulin treatment.
The addition of insulin (1 i. Table 7 it would seem that no consistent pattern can be detected for all five enzymes. However, the two enzymes comprising the arginine-synthetase system appear to vary together, with argininosuccinate activity increasing slightly more than that ofargininosuccinate synthetase. This finding is consistent with the arginine-synthetase system being rate-limiting in urea formation and represents another example of control of a metabolic pathway by the activity of the rate-limiting enzyme. It is also evident from Table 7 that diabetes and glucagon treatment produce changes that are closely similar to each other but different from the changes caused by the other conditions listed. This is chiefly notable in the activity of carbamoyl phosphate synthetase, where a disproportionate increase is found in high-protein diet, starvation and cortisone treatment. Ornithinetranscarbamoylase and arginase activities, when considered in relation to the change in that of argininosuccinate synthetase, do not vary greatly in the five conditions, a finding probably best explained in terms of the high potential activities of these enzymes. Under optimum conditions these two enzymes have activities 100-fold (for ornithine transcarbamoylase) and 1000-fold (for arginase) that of the rate-limiting enzyme. However, these optimum rates may bear little relation to activity in Vol. 94 vivo, particularly since the substrate concentrations are different from those used in the assay system. The activities of carbamoyl phosphate synthetase and ornithine transcarbamoylase, the two mitochondrial enzymes, do not vary together, i.e. their total activity is not simply a function of mitochondrial numbers. The close similarity between the overall pattern of diabetic and glucagon-treated rats emphasizes the point that an alloxan-diabetic rat may, in this respect, be regarded as a glucagon-treated animal. Since insulin and glucagon have antagonistic actions, the destruction of the ,B-cells by alloxan treatment leaves the animal subject only to glucagon. Although the rate of glucagon secretion may be lower in a diabetic animal than in a normal, as the rate of secretion is partly governed by the blood sugar (Unger, Eisentraut, McCall & Madison, 1962) , even a small rate in the absence of insulin could exert a dramatic effect (Tyberghein, 1961) . That the magnitude of the effect of treatment of normal rats with glucagon is rather less than that observed in the diabetic may be explained by the relatively short half-life of injected glucagon (Berson, Yalow, & Volk, 1957; Cox, Henley, Narahara, Van Arsdel & Williams, 1957) , together with the antagonistic effect of insulin. This antagonistic action is well illustrated in the experiments of Miller ( 1960 Miller ( , 1961 , in which it was shown that the protein-catabolic effect of glucagon in a perfused liver preparation could be abolished by insulin, whereas its glycogenolytic action was unimpaired.
In view of the many different results that have been published on the effect of diabetes on the concentrations ofcofactors and enzymes (see de Duve & Hers, 1957) , results obtained on rats in diabetic coma are included here (Table 3) . These animals show a very different pattern of enzyme change, and only argininosuccinase has an activity greater than that found in control rats, illustrating that increasing severity ofthe diabetic condition does not necessarily accentuate the changes found in the milder condition.
Treatment of diabetic rats with protamine-zincinsulin gives the surprising result of an increase in the activities of the three enzymes found in the cytoplasmic fraction, an increase largely due to the increased liver weight caused by this treatment. It is not until after 4 days of protamine-zinc-insulin treatment that the activities of these enzymes begin to fall. The slow response of the urea-cycle enzymes compared with the action of insulin in restoring carbohydrate and fat metabolism is in keeping with the observation of Haft & Miller (1958) , who found that the large increase in ureogenesis in perfused liver of diabetic rats was not modified by insulin, even though this treatment altered the blood sugar concentration and lipogenesis. The increase in total liver RNA P in (liabetic rats treated with insulin (Table 6 ) is in keeping with the observations of Leslie & Davidson (1951) , who found that insulin caused an increase in RNA P in embryonic tissues growing in vitro, and of Wool & Munro (1963) , who found that insulin enhanced RNA synthesis in muscle.
The increase in the activities of urea-cycle enzymes with glucagon treatment and in diabetic rats treated with insulin is also of interest in relation to the work of Salter, de Meyer & Best (1958) and Best (1959) on the inhibition of tumour growth, particularly Walker carcinoma, by combined glucagon and insulin treatment. The increase in these enzymes, important in the catabolism of amino acids, may have some bearing on their observations. Control of metabolic pathways can be at the substrate level, as well as by changes in enzyme concentration. Of the amino acids immediately associated with the urea cycle Schimke (1963) has shown that the intracellular concentration of ornithine, citrulline and arginine remained relatively constant under a wide variety of conditions in which there are significant differences in enzyme activity and urea excretion. These results suggest control of urea-cycle activity by feedback mechanisms, a point raised by Flores, Rosado, Torres & Soberon (1962) with respect to citrulline concentration in livers of carbon tetrachloride-treated rats. This particular amino acid might be expected to change in concentration, since the potential rate of synthesis is much greater than the rate ofits removal by the rate-limiting step argininosuccinate synthetase, an enzyme that alters markedly in different physiological conditions. The work of Gornall & Hunter (1943) , showing that high concentrations of ornithine lead to an accumulation ofcitrulline and, in very high concentrations, cause a decrease in urea output by liver slices, is also relevant here. The complexities of the control mechanisms are also illustrated by the evidence that liver arginase is inhibited by ornithine (Edlbacher & Zeller, 1936; Bach, Crook & Williamson, 1944) . It is, presumably, the balance of these control mechanisms that maintains the three amino acids of the urea cycle within the narrow range of concentration found by Schimke (1963) .
Other amino acids closely integrated with the urea cycle are aspartic acid, which donates an amino group in the argininosuccinate-synthetase reaction, and glutamic acid, which is linked by way of glutamate dehydrogenase (see Ratner, 1954, p. 399) .
The direction of this latter enzyme reaction is greatly influenced by the oxidation-reduction state of the nicotinamide nucleotides. The concentration of aspartic acid in the liver falls dramatically in diabetic rats, whereas that of glutamic acid remains relatively unchanged (Kirsten, Kirsten, Hohorst & Biucher, 1961) . This, together with the increase in the amount of NADH relative to NAD+ (Glock & McLean, 1955; Hohorst, Kreutz & Reim, 1961 ) (a point, incidentally, on which there is no general agreement; see also Helmreich, Holzer, Lamprecht & Goldschmidt, 1954; Greenbaum & Graymore, 1956) , suggests that these substrate and coenzyme changes are in part a result of rather than a causative effect of the increased urea output in diabetic rats.
Of the other factors required for urea synthesis, the concentration of ATP may be lowered in the diabetic state (see Krahl, 1961 ) . Carbon dioxide may also be deficient, as shown by Frohman & Orten (1956) , who found that the administration of bicarbonate corrected some defects in the tricarboxylic acid cycle. No information appears to be available on the concentration of N-acetylglutamic acid in diabetic animals, although the concentration of pyridoxal phosphate, the cofactor for transamination reactions, is unchanged in diabetes (Fasella, Baglioni, Turano & Siliprandi, 1960) . Changes in the activities of some ofthe enzymes associated with the urea cycle have also been reported. Transaminase activity is increased in diabetic rats (Copenhaver, Shipley & Meyer, 1951; Rosen, Roberts, & Nichol, 1959; Fitch & Chaikoff, 1962) and in glucagon-treated rats (Okuno, 1960) . Fitch & Chaikoff (1962) have found an increase in fumarase activity in diabetic rats. These authors drew attention to the fact that about one-third of the amino acids found in proteins pass through fumarate during gluconeogenesis. The increased activity of this enzyme may also be of significance in relation to the equilibrium position of argininosuccinase (Ratner, Anslow & Petrack, 1953) , the action of which is to produce arginine and fumarate.
The enzyme changes shown in the present study appear to fit the metabolic pattern characteristic of diabetes. However, the time-sequence of change in relation to the insulin response suggests that the primary effect of insulin is not located in the urea cycle, the changes of which constitute only a part of the very comprehensive adaptations occurring in diabetic and glucagon-treated rats.
We In a study of some control mechanisms of ureacycle enzymes it was observed that the addition of urea appeared to potentiate the activity of carbamoyl phosphate synthetase (adenosine triphosphate-carbamate phosphotransferase; EC 2.7.2.1). Since this enzyme is measured by the amount of citrulline formed and both citrulline and urea react with diacetylmonoxime (Archibald, 1944) , an investigation of the possible interaction of citrulline and urea in this diacetylmonoxime reaction was undertaken. The work of Fearon (1939) and Gornall & Hunter (1941) had already indicated the possibility of interactions of the type described below. Gornall & Hunter (1941) in fact found that tissue filtrates contained material that increased the colour reaction of citrulline in the diacetylmonoxime reaction of Fearon (1939) , and they removed the interfering material with urease. In the present study it was found that when urea and citrulline were present together the resultant colour formed with diacetylmonoxime was greater than the sum of the two compounds measured independently. In conditions where high amounts of urea are present, as, for example, in preparations from alloxandiabetic rat livers, this interference may assume considerable importance in the assay of the two urea-cycle enzymes that are measured by the amount of citrulline formed, i.e. carbamoyl phosphate synthetase and ornithine transcarbamoylase (carbamoyl phosphate-L-ornithine carbamoyltransferase, EC 2.1.3.3.)
The present work reports the interaction of citrulline with urea and with a number ofsubstituted ureas in the colour reaction with diacetylmonoxime described by Archibald (1944) , and gives a method for correcting for this interference. METHODS Material8. Commerical reagents were used with the exception of a-isonitrosopropiophenone, which was synthesized by the method of , and carbamoylglycine, which was a gift from Dr Margaret Foulkes, Westminster Hospital, London. Carbamoylaspartate and carbamoylglutamate were obtained from Sigma Chemical Co., St Louis, Mo., U.S.A.
Diacetylmonoxime reaction. The diacetylmonoxime reaction for citrulline described by Archibald (1944) was used, the only modification being that the heating time was extended from 10 to 15 min. to obtain more reproducible results. Precautions were taken to exclude light during colour development. Citrulline and urea, or substituted ureas, were heated singly and in combination together with diacetylmonoxime, and the absorption and difference spectra were determined. The values reported in Table 1 and Figs. 3 and 4 are for El c%m the absorption maximum for the colour developed with citrulline. A Hilger Uvispek spectrophotometer was used.
ce-Isonitro8opropiophenone reaction. The colour reaction with %-isonitrosopropiophenone (Archibald, 1945) Fig. 1 . This difference spectrum is obtained from the data in Fig. 2 Fig. 3 . This shows the reaction of urea, urea plus citrulline + urea (60 lg.); B, absorption spectra for urea (60 ,lg.) alone. The difference between these two is shown by the citrulline difference spectra in Fig. 1 . The colour reaction of Archibald (1944) (Archibald, 1944) (60 ,ug.) citrulline. This effect is reproducible provided that the time of heating is carefully controlled. Correction as applied to carbanoyl phosphatesynthetase assay. In extracts where appreciable amounts ofurea are present, as in livers from alloxan diabetic rats, the urea content of the tissue alone must be determined separately, for example by the sensitive colorimetric method with a-isonitrosopropiophenone described by Archibald (1945) . The citrulline calibration curve is then determined in the presence ofthe appropriate amount ofurea, and thin curve used in the calculation of the activity of carbamoyl phosphate synthetase. The amount of enzyme used for the assay of ornithine transcarbamoylase is so small (0.01 ml. of supernatant fraction from a 1:10 liver homogenate prepared in 0I1% cetyltrimethylammonium bromide) that no such correction is necessary for this enzyme. The magnitude of the correction factor may be judged by the fact that the value for the 30 ,ug. of Table 1 . Effect of urea and 8ome 8ub8tituted ureas on the colour reaction of citrulline and diacetylmonoxime The colour reaction of Archibald (1944) show that the absorption maxima for these compounds are close to those for urea and citrulline, and are 485 and 495 m,u for methylurea and phenylurea respectively. Archibald (1944) has reported that allantoin reacts with diacetylmonoxime to give a coloured product, but with the concentrations used in the present work very little colour was produced.
The carbamoyl derivatives of amino acids are of interest in this context, and in particular carbamoylaspartic acid, which is one ofthe first products in the pathway of pyrimidine formation. There is an inverse relationship between the activity of ornithine transcarbamoylase and aspartate transcarbamoylase in certain conditions where rapid growth is taking place and there is a high requirement for pyrimidine for DNA and RNA synthesis (see Cohen & Sallach, 1961 Vol. 94 425 tested only carbamoylglycine gave a positive reaction with diacetylmonoxime and potentiated the colour with citrulline; carbamoylglutamic acid did not have either of these properties. There is not yet sufficient information to enable speculation on the structure of compounds reacting in this way with citrulline and diacetylmonoxime beyond the generalizations given by Fearon (1939) , although the difference between carbamoylglycine and carbamoylaspartic acid perhaps suggests that ring-closure in acid solution with the latter compound might account for the lack of reaction.
